Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
TRI VALLEY CORPListing unverified | Buy | $15.3K | conv 12 | SEC | |
TRI VALLEY CORPListing unverified | Buy | $55.2K | conv 23 | SEC | |
TRI VALLEY CORPListing unverified | Buy | $208.3K | conv 34First in 12mo | SEC | |
TRI VALLEY CORPListing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
TRI VALLEY CORPListing unverified | Other | $122K | SEC | ||
TRI VALLEY CORPListing unverified | Other | $67.5K | SEC | ||
TRI VALLEY CORPListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
TRI VALLEY CORPListing unverified | Other | $121.5K | SEC | ||
TRI VALLEY CORPListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
TRI VALLEY CORPListing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Trillium Therapeutics Inc.Listing unverified | Buy | $31.7K | conv 38First in 12mo | SEC |